Is there a difference in demography and clinical characteristics in patients treated with and without bevacizumab?
Holger
H
Hartmann
Judith
J
Müller
Norbert
N
Marschner
D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000401:mortality*; D005260:Female; D006801:Humans; D008297:Male; D006278:Medicare / Q000706:statistics & numerical data*
D061067:Antibodies, Monoclonal, Humanized